Delivery Order SPE2DB20D2104-SPE2DB22FR89G
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $20,862.84 firm-fixed-price delivery order is for the pharmaceutical product Myrbetriq ER 25 mg tablets. The contract has an ultimate completion date of October 30, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DX24FMCVF) valued at $7,216.05 for the supply of Myrbetriq ER 50 MG tablets. The contract, with a performance period through May 3, 2024, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00, which serves as the primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,812.43 delivery order is for the pharmaceutical product Myrbetriq ER 25 mg tablets, with an ultimate completion date of August 11, 2021. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $20,931.69 firm fixed-price delivery order is for the supply of Myrbetriq ER 25 mg tablets. The contract has an ultimate completion date of October 19, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,870.59 and covers the delivery of Myrbetriq ER 25 mg tablets. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $8,775.07 for the medication Myrbetriq ER 50 mg tablets. The award was made on August 4, 2021, with a completion date of August 5, 2021. The contracting agency is the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November...
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Myrbetriq ER 50 mg tablets. The contract has a ceiling value of $4,672.95 and an ultimate completion date of February 15, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of Myrbetriq ER 50 mg tablets to the Defense Logistics Agency (DLA) under a firm-fixed price delivery order. The $16,594.29 contract, awarded on April 12, 2022, has an ultimate completion date of April 13, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company and wholly-owned subsidiary of Cencora, Inc. The $28,159.98 firm-fixed-price delivery order is for Myrbetriq ER 50 mg tablets to be delivered by June 2, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $10,157.20 firm fixed-price delivery order is for the pharmaceutical product Myrbetriq ER 50 MG Tablet 90s. The contract has an ultimate completion date of December 28, 2023. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FR89GDelivery Order
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., covers the delivery of Myrbetriq ER 50 mg tablets. The $71,722.97 firm fixed-price delivery order has a period of performance through February 23, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary mechanism for the company to provide a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not include any set-aside designations, indicating open competition. The products delivered under this contract are critical medications used to treat various medical conditions and support the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $71.7k | 2/22/22 |